Al activar estos receptores, se retrasa el vaciado gstrico y se refuerzan las seales de saciedad, lo que puede contribuir a reducir la ingesta de energa
Regulatory Shifts May Play a Role If the FDA broadens the approved use of GLP-1s or legislation changes how weight-loss drugs are classified for insurance purposes, employer decisions may shift accordingly
doi: 10.1677/joe.0.1650079 137 JohnsonJWMitznerWLondonWTPalmerAEScottR
Dublin, OH, and San Francisco, CA (March 20, 2025) Quantum Health, the leader in healthcare navigation and care coordination, announced today it has expanded its Premier Pharmacy platform to offer self-insured employers a new GLP-1 solution powered by Vida Health optimizing prescribing patterns, clinical outcomes and member support for weight loss
Elevate your wellness today
Smoothes, firms, and tones the skin